The University's Medical Center will receive a free supply of the drug Taxol as a result of a recent legal settlement, according to the Hampton Roads Daily Press.
States involved in the lawsuit claimed Bristol-Myers Squibb tried to keep the generic form of Taxol from reaching the market. As a result, Bristol-Myers Squibb must distribute vials of Taxol to medical centers around the country.
Taxol, or paciltaxel, is a chemotherapy drug used mostly in the treatment of ovarian and breast cancer, according to the University Health System Web site. It costs between $6,000 and $10,000 per patient for a standard course treatment.
In addition to receiving the vials of Taxol, the University Medical Center will receive compensation from Bristol-Myers Squibb for being overcharged for Taxol in the past. Around the country, $12 million will be spent reimbursing patients who overpaid for the drug, according to the Daily Press.
To qualify for the free Taxol, patients cannot have primary insurance, Medicare or Medicaid, and they must fall under a certain household income level.
According to the University Medical Center Web site, Taxol is a somewhat controversial drug because the American Cancer Society and National Cancer Institute have both said the risks involving Taxol outweigh the benefits.
--Compiled by Johanna Cluver
Read More
How does U.Va.’s agreement with the Justice Department compare to the Compact?
By Nicolas Biernacki | 13 hours agoWhile both the rejected Compact and the Justice Department agreement faced resistance from the University community and have several similarities, the agreement provides firmer protection for academic freedom.
New residential college policy prioritizes rising second-years in rehousing assignments
By Brandon Kile | 13 hours agoA new on-Grounds housing policy concerning residential colleges will change the reapplication system to give rising second years who are returning to the colleges priority in the housing process.
Paul Cherukuri leads U.Va.’s entrepreneurship strategy as its first chief innovation officer
By Bertie Azqueta | YesterdayPaul Cherukuri was recently named the University’s first chief innovation officer in August, a role within the Office of the Vice President for Research that was created to help expand student entrepreneurship and start-up activity at the University.
